These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 22049225)

  • 1. Tumour-infiltrating macrophages and clinical outcome in breast cancer.
    Mahmoud SM; Lee AH; Paish EC; Macmillan RD; Ellis IO; Green AR
    J Clin Pathol; 2012 Feb; 65(2):159-63. PubMed ID: 22049225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The presence of tumor associated macrophages in tumor stroma as a prognostic marker for breast cancer patients.
    Medrek C; Pontén F; Jirström K; Leandersson K
    BMC Cancer; 2012 Jul; 12():306. PubMed ID: 22824040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prognostic significance of B lymphocytes in invasive carcinoma of the breast.
    Mahmoud SM; Lee AH; Paish EC; Macmillan RD; Ellis IO; Green AR
    Breast Cancer Res Treat; 2012 Apr; 132(2):545-53. PubMed ID: 21671016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Higher density of stromal M2 macrophages in breast ductal carcinoma in situ predicts recurrence.
    Chen XY; Thike AA; Md Nasir ND; Koh VCY; Bay BH; Tan PH
    Virchows Arch; 2020 Jun; 476(6):825-833. PubMed ID: 31897820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macrophages as independent prognostic factors in small T1 breast cancers.
    Carrio R; Koru-Sengul T; Miao F; Glück S; Lopez O; Selman Y; Alvarez C; Milikowski C; Gomez C; Jorda M; Nadji M; Torroella-Kouri M
    Oncol Rep; 2013 Jan; 29(1):141-8. PubMed ID: 23076599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Independent prognostic impact of tumour-infiltrating macrophages in early-stage Hodgkin's lymphoma.
    Gotti M; Nicola M; Lucioni M; Fiaccadori V; Ferretti V; Sciarra R; Costanza M; Bono E; Molo S; Maffi A; Croci GA; Varettoni M; Frigeni M; Pascutto C; Arcaini L; Bonfichi M; Paulli M; Cazzola M
    Hematol Oncol; 2017 Sep; 35(3):296-302. PubMed ID: 27060262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD68, CD163, and matrix metalloproteinase 9 (MMP-9) co-localization in breast tumor microenvironment predicts survival differently in ER-positive and -negative cancers.
    Pelekanou V; Villarroel-Espindola F; Schalper KA; Pusztai L; Rimm DL
    Breast Cancer Res; 2018 Dec; 20(1):154. PubMed ID: 30558648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The intratumoral distribution influences the prognostic impact of CD68- and CD204-positive macrophages in non-small cell lung cancer.
    Li Z; Maeda D; Yoshida M; Umakoshi M; Nanjo H; Shiraishi K; Saito M; Kohno T; Konno H; Saito H; Minamiya Y; Goto A
    Lung Cancer; 2018 Sep; 123():127-135. PubMed ID: 30089583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical Expression of CD47 and CD68 in Breast Carcinoma and Their Prognostic Value.
    Alhanafy S; Hany H; Nasef K; El-Salkh I; Elhawary A
    Asian Pac J Cancer Prev; 2024 Jul; 25(7):2515-2527. PubMed ID: 39068587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An evaluation of the clinical significance of FOXP3+ infiltrating cells in human breast cancer.
    Mahmoud SM; Paish EC; Powe DG; Macmillan RD; Lee AH; Ellis IO; Green AR
    Breast Cancer Res Treat; 2011 May; 127(1):99-108. PubMed ID: 20556505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathologic assessment of tumor-associated macrophages and their histologic localization in invasive breast carcinoma.
    Mwafy SE; El-Guindy DM
    J Egypt Natl Canc Inst; 2020 Jan; 32(1):6. PubMed ID: 32372332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The M2 phenotype of tumor-associated macrophages in the stroma confers a poor prognosis in pancreatic cancer.
    Hu H; Hang JJ; Han T; Zhuo M; Jiao F; Wang LW
    Tumour Biol; 2016 Jul; 37(7):8657-64. PubMed ID: 26738860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterisation of tumour-infiltrating macrophages: impact on response and survival in patients receiving primary chemotherapy for breast cancer.
    Heys SD; Stewart KN; McKenzie EJ; Miller ID; Wong SY; Sellar G; Rees AJ
    Breast Cancer Res Treat; 2012 Sep; 135(2):539-48. PubMed ID: 22886449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of CD68/(CD3+CD20) ratio at the invasive front of primary tumors on distant metastasis development in breast cancer.
    Eiró N; Pidal I; Fernandez-Garcia B; Junquera S; Lamelas ML; del Casar JM; González LO; López-Muñiz A; Vizoso FJ
    PLoS One; 2012; 7(12):e52796. PubMed ID: 23300781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High tumor-infiltrating macrophage density predicts poor prognosis in patients with primary hepatocellular carcinoma after resection.
    Ding T; Xu J; Wang F; Shi M; Zhang Y; Li SP; Zheng L
    Hum Pathol; 2009 Mar; 40(3):381-9. PubMed ID: 18992916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The predominance of M2-polarized macrophages in the stroma of low-hypoxic bladder tumors is associated with BCG immunotherapy failure.
    Lima L; Oliveira D; Tavares A; Amaro T; Cruz R; Oliveira MJ; Ferreira JA; Santos L
    Urol Oncol; 2014 May; 32(4):449-57. PubMed ID: 24252833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High numbers of macrophages, especially M2-like (CD163-positive), correlate with hyaluronan accumulation and poor outcome in breast cancer.
    Tiainen S; Tumelius R; Rilla K; Hämäläinen K; Tammi M; Tammi R; Kosma VM; Oikari S; Auvinen P
    Histopathology; 2015 May; 66(6):873-83. PubMed ID: 25387851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor-associated macrophages and crown-like structures in adipose tissue in breast cancer.
    Cha YJ; Kim ES; Koo JS
    Breast Cancer Res Treat; 2018 Jul; 170(1):15-25. PubMed ID: 29468486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated Levels of TNF-α and Decreased Levels of CD68-Positive Macrophages in Primary Tumor Tissues Are Unfavorable for the Survival of Patients With Nasopharyngeal Carcinoma.
    Yu Y; Ke L; Xia WX; Xiang Y; Lv X; Bu J
    Technol Cancer Res Treat; 2019 Jan; 18():1533033819874807. PubMed ID: 31522611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune cells within tertiary lymphoid structures are associated with progression-free survival in patients with locoregional recurrent breast cancer.
    Gu J; Wang J; Sun Y; Mao X; Qian C; Tang X; Wang J; Xie H; Ling L; Zhao Y; Liu X; Zhang K; Pan H; Wang S; Wang C; Zhou W
    Cancer Med; 2024 Jan; 13(1):e6864. PubMed ID: 38133211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.